Table 3.
Correlations between LVM index and other factors during linear regression analysis
|
Univariate linear regression |
Multivariate stepwise regression |
|||
|---|---|---|---|---|
| β | P | β | P | |
| Age | −0.205 | 0.039 | −0.016 | 0.856 |
| LVDd | 0.167 | 0.093 | 0.241 | 0.005 |
| IVS | 0.225 | 0.025 | 0.392 | 0.001 |
| PWT | 0.228 | 0.005 | 0.128 | 0.248 |
| TG, mmol/L | 0.185 | 0.063 | 0.120 | 0.138 |
| NAFL | 0.248 | 0.012 | 0.139 | 0.039 |
| LV fibrosis size | 0.296 | 0.003 | 0.170 | 0.044 |
| Sex | −0.155 | 0.119 | – | |
| BMI | 0.107 | 0.283 | ||
| Weight | 0.158 | 0.113 | ||
| LVSd | 0.137 | 0.131 | ||
| LVEF | −0.120 | 0.230 | ||
| ICM | −0.500 | 0.538 | ||
| DM | 0.127 | 0.203 | ||
| CKD | 0.113 | 0.753 | ||
| Hypertension | −0.156 | 0.117 | ||
| Smoking | 0.047 | 0.562 | ||
| NT-proBNP | 0.016 | 0.871 | ||
| TC, mmol/L | 0.020 | 0.842 | ||
| LDL, mmol/L | −0.093 | 0.353 | ||
| HDL, mmol/L | −0.107 | 0.283 | ||
LVM, left ventricular mass; BMI, body mass index; LVDd, left ventricular diastolic diameter; LVSd, left ventricular systolic diameter; LVEF, left ventricular ejection fraction; IVS, interventricular septum; PWT, posterior wall thickness; NAFL, nonalcoholic fatty liver; ICM, ischemic cardiomyopathy; DM, diabetes mellitus; CKD, chronic kidney disease, TG, triglycerides; NT-proBNP, N-terminal pro B-type natriuretic peptide; TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein.
P ≤ 0.1 and P ≤ 0.05 were regarded as statistically significant during univariate linear regression and multivariate stepwise regression, respectively.